Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an electrolyte replacement that is essential for nerve conduction, muscle contraction, and maintaining acid-base balance. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
## Adult Dosing
**Oral:**
* **Prevention:** 20 mEq (1.5 g) per day, divided into 1 or 2 doses.
* **Treatment:** 40-100 mEq (3-7.5 g) per day, divided into 2-4 doses. Maximum daily dose is typically 200 mEq (15 g) per day, but should not exceed 20 mEq per dose or 10 mEq per hour in patients with impaired renal function.
**Intravenous (IV):**
* **General Correction:** Typically 10-20 mEq (0.75-1.5 g) per hour. Maximum infusion rate is usually 10 mEq (0.75 g) per hour in peripheral lines and 20 mEq (1.5 g) per hour in central lines, unless the patient is on cardiac monitoring.
* **Severe Hypokalemia/ECG Changes:** May require higher doses and faster rates under continuous ECG monitoring.
* **Total Daily Dose:** Rarely exceeds 200 mEq (15 g) per day.
*Specific dosing may depend on local protocol and patient-specific electrolyte levels and clinical status.*
## Pediatric Dosing
**Oral:**
* **Prevention:** 1-2 mEq/kg/day, maximum 100 mEq/day.
* **Treatment:** 2-5 mEq/kg/day, maximum 200 mEq/day, divided into 2-4 doses.
**Intravenous (IV):**
* **General Correction:** 0.5-1 mEq/kg/hour, maximum 2 mEq/kg/hour or 20 mEq/hour.
* **Total Daily Dose:** Typically 100 mEq/kg/day, maximum 200 mEq/day.
*Specific dosing requires careful calculation based on age, weight, and potassium levels, and often follows institutional guidelines.*
## Dose Adjustments
* **Renal Impairment:** Reduced doses and slower infusion rates are necessary due to the risk of hyperkalemia. Close monitoring of serum potassium is crucial.
* **Adrenal Insufficiency:** Patients may be more susceptible to hyperkalemia.
## Contraindications
* Hyperkalemia.
* Conditions that predispose to hyperkalemia, such as severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue injury, or the administration of potassium-sparing diuretics.
* Known hypersensitivity to potassium chloride.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence.
* **Serious:** Hyperkalemia (manifesting as muscle weakness, paresthesias, cardiac arrhythmias, cardiac arrest), esophageal or gastrointestinal ulceration/perforation (with oral forms, especially if not taken with sufficient fluid or in patients with delayed gastric emptying).
* **IV specific:** Phlebitis, pain at injection site, vein irritation.
## Key Drug Interactions
* **ACE inhibitors, ARBs, Potassium-sparing diuretics (e.g., spironolactone, amiloride), NSAIDs, Heparin, Trimethoprim:** Increased risk of hyperkalemia.
* **Sodium-restricted foods/substitutes:** May contain potassium; increased potassium intake.
* **Digitalis glycosides:** Hyperkalemia may potentiate digitalis toxicity. Hypokalemia may decrease digitalis efficacy.
## Monitoring
* **Serum electrolytes:** Especially potassium, sodium, and chloride, at baseline and periodically during treatment.
* **Renal function:** Serum creatinine and BUN.
* **ECG:** Especially in patients receiving IV potassium, those with significant hypokalemia, or those at risk for hyperkalemia.
* **Signs and symptoms of hypokalemia and hyperkalemia.**
## Clinical Pearls
* Administer oral potassium chloride with sufficient fluid (at least 8 ounces) to minimize gastrointestinal irritation.
* Do not crush or chew sustained-release formulations.
* IV potassium chloride is hyperosmolar and can cause pain and phlebitis; infuse slowly and dilute appropriately, preferably via a central line for higher concentrations.
* Rapid IV infusion of potassium can be fatal.
* Always confirm the correct potassium concentration and infusion rate with another licensed healthcare professional before administration.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace comprehensive drug information resources. Always consult the most current prescribing information and institutional guidelines before making any clinical decisions.
